Clinical Evaluation of VirtualDose - a Software for Tracking and Reporting CTDI, DLP, Organ and Effective Dose for Adult and Pediatric Patient
A Ding1*, Y Gao1, P Caracappa1, D Long2, W Bolch2, B Liu3, M Kalra,3, X Xu1, (1) Rensselaer Polytechnic Institute, Troy, NY, (2) University of Florida, Gainesville, Florida, (3) Massachusetts General Hospital, Boston, MATU-G-103-2 Tuesday 4:30PM - 6:00PM Room: 103
To update the development and clinical testing of a new Software as a Service (SaaS) -VirtualDose for tracking and reporting CT doses.
VirtualDose has been developed as a CT dose reporting SaaS by offering a web-based dynamic user-friendly interface. Based on the user-specified scanning parameters, VirtualDose rapidly report the organ dose data from the remote server-side database and interactively tabulate and plot the results of interest within a web browser. Clinical testing found the dose up to 24% different as compared to those derived from the stylized MIRD-type phantoms. The morbidly obese phantom received up to 60% smaller CT dose than that of the normal weight phantom
VirtualDose is now available in the following website: http://www.virtualphantoms.com and being tested at more than 20 medical centers nationwide. Using a large library of adult and pediatric phantoms, it provides more accurate dose data and is expected to improve both the accuracy and usability in CT dose reporting in the future.